Risk Assessment and Risk-Adapted Treatment Selection: A Case-Based Approach for Chronic Lymphocytic Leukemia
Sandra Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP
University of Arizona and Arizona Cancer Center, Tucson, Arizona
Authors’ disclosures of potential conflicts of interest are found at the end of this article.
Sandra Kurtin, PhDc, ANP-C, AOCN®, University of Arizona and Arizona Cancer Center, 3838 North Campbell Avenue, Tucson, AZ 85719. E-mail: Sandra.Kurtin@bannerhealth.com
J Adv Pract Oncol 2017;8:502–520 |
© 2017 Harborside Press®
Selected Patient Cases From the APSHO Regional Lecture Series
As the official publication of the Advanced Practitioner Society for Hematology and Oncology (APSHO), JADPRO is pleased to offer Part 3 of an accredited educational activity based on the recently concluded APSHO Regional Lecture Series. Hosted in collaboration with major cancer centers around the country, the APSHO Regional Lecture Series brought case-based didactic presentations and skills workshops to advanced practitioners.
In the spirit of JADPRO, three accredited Grand Rounds articles by Beth Eaby-Sandy, MSN, CRNP, OCN® (non–small cell lung cancer) and Sandra Kurtin, PhDc, ANP-C, AOCN® (multiple myeloma and chronic lymphocytic leukemia)—program chairs for the regional lecture series—offer the same practice-changing information and strategies for advanced practitioners.
In this Grand Rounds article, program chair Sandra Kurtin reviews the prognosis, risk assessment, and treatment for patients with chronic lymphocytic leukemia and assesses four case studies.
You can read Parts 1 and 2 in previous issues of JADPRO or online at advancedpractitioner.com. Check out apsho.org/lectures for information on registering for upcoming JADPRO Regional Lectures this year at a location near you.
For access to the full length article, please sign in